HHS purchases 650K courses of antibody treatment
The White House and U.S. Department of Health and Human Services announced they've purchased over 650,000 courses of of Eli Lilly's monoclonal antibody treatment for high-risk patients.
The treatment, bamlanivimab, can reduce the risk of severe coronavirus symptoms before someone becomes hospitalized.
The treatment will be deployed in December and January and complement the 300,000 doses that are currently being distributed, according to HHS.
Eli Lilly received emergency use authorization for bamlanivimab from the Food and Drug Administration last month.
-ABC News' Stephanie Ebbs